mammary gland hyperplasia_Tg(MMTV-PTGS2)#Thla/0

http://metadb.riken.jp/0000630I129S6SvEvTacC57BL6CD1FVBNTgMMTVPTGS2Thla0TgMMTVPTGS2Thla

mammary gland hyperplasia_Tg(MMTV-PTGS2)#Thla/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion, Timothy Hla
  http://metadb.riken.jp/db/mgi_rdf/MGI:4834852

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(MMTV-PTGS2)#Thla/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(MMTV-PTGS2)#Thla

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• mammary gland hyperplasia
  http://purl.obolibrary.org/obo/MP_0000630

文献

http://purl.org/net/cito/citesAsAuthority

• Sung-Hee. Chang, et.al., The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia., Cancer research, 2005, 65
  http://rdf.ncbi.nlm.nih.gov/pubmed/15930264